AstraZeneca and Pfizer/BioNTech: Germany Faces Dilemma of What to do with Excess Vaccine Times of News 3 years ago A vaccine warehouse in the state of Saxony-Anhalt Foto: Ronny Hartmann / dpa-Zentralbild Article source: https://www.spiegel.de/international/germany/astrazeneca-and-pfizer-biontech-germany-faces-dilemma-of-what-to-do-with-excess-vaccine-a-6e13668e-0a1a-4251-821b-ff3eb3c7bbd9#ref=rssShare this: